Losartan Brown Fat Study: Can a BP Pill Fire Up Metabolism?

A common blood pressure pill might also wake up your body's calorie-burning tissue, and the losartan brown fat link is the health story people are sharing this week. Researchers published the finding in Nature on October fourteenth, and the labs behind it have been talking about it ever since.

What the researchers actually found

Brown fat is the tissue that burns energy to make heat, while white fat just stores it. According to the National Institutes of Health, scientists showed that losartan, a drug widely prescribed for high blood pressure, boosts brown fat activity in mice and enhances their metabolism.

The team, led by Paul Cohen at Rockefeller University, did not start with the drug. They started with scans. A type of PET/CT imaging used in cancer care can measure brown fat activity, so the researchers mined images and medical records from more than one hundred thousand patients treated for cancer.

A giant data dive, powered by AI

Cohen's group had already linked brown fat to lower rates of heart and metabolic disease in an earlier paper. This time they went much bigger. "We doubled our number of patients and considered more than five hundred codes, which allowed us to unearth many new insights," Cohen said, as quoted by NIH.

They used artificial intelligence tools to pull brown fat signals out of the imaging. They also looked at six separate brown fat depots in the body. Activity in the armpit area was most strongly tied to better cardiometabolic health, and Weill Cornell Medicine notes that region was linked to a lower risk of high blood pressure.

Why losartan stood out

One signal jumped off the page. Patients taking a class of drugs called angiotensin receptor blockers, or ARBs, had more brown fat activity. Losartan is one of those drugs, so the team tested it directly on brown fat cells in the lab.

The drug increased the cells' metabolic activity. Healthy mice given losartan showed higher energy expenditure, more oxygen use and more carbon dioxide production, all while their body weight stayed steady. According to Weill Cornell Medicine, the pathways losartan uses on brown fat are different from the ones that lower blood pressure.

That matters because it hints the effects could be separated one day. Lead author Nicolás Gómez-Banoy said that difference could let doctors stimulate brown fat in people with normal blood pressure.

The mental health twist

The study also reported a first. People with more brown fat had a lower incidence of anxiety and depression. Gómez-Banoy cautioned that metabolically healthy people tend to have fewer psychiatric problems, so brown fat may be a marker of overall metabolic health rather than a direct mood booster.

The researchers also noticed that SSRIs, which are commonly prescribed for depression, appeared to dampen brown fat activity. That is an association in the data, not a reason for anyone to change medication.

What this does not mean

Here is the reality check. The drug experiments were done in cells and mice, and Weill Cornell describes the work as preclinical. Nobody has shown that losartan brown fat activation helps people lose weight or protects them from disease.

So do not ask a doctor for a blood pressure pill to burn fat, and do not start taking one. Losartan is a prescription drug with real effects, and the study offers no dosing advice. What it gives science is a clue and a safe, well-studied drug to test in future human trials.

What comes next

The authors say the findings open several paths: testing drugs beyond losartan, studying the genetics of people with high brown fat levels, and digging into the link with anxiety and depression. "There were plenty of other medications associated with brown fat activity in our large cohort," Cohen said. "This is just a start."

For a generation that treats metabolism like a mystery box, this is a good reminder that the science is moving fast but still early. Watch for human trials, and keep an eye on our health coverage for updates.